FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
-4.45%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$18.3B
AUM Growth
-$3.9B
(-18%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-11%
Top 10 Holdings %
Top 10 Hldgs %
30.49%
Holding
560
New
66
Increased
141
Reduced
222
Closed
94
Top Buys
| 1 |
Microsoft
MSFT
|
$312M |
| 2 |
Yum! Brands
YUM
|
$211M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$192M |
| 4 |
CELG
Celgene Corp
CELG
|
$185M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$171M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$258M |
| 2 |
Blackstone
BX
|
$220M |
| 3 |
Cigna
CI
|
$216M |
| 4 |
Hartford Financial Services
HIG
|
$204M |
| 5 |
CVS Health
CVS
|
$182M |
Sector Composition
| 1 | Healthcare | 23.98% |
| 2 | Technology | 17.01% |
| 3 | Consumer Discretionary | 15.78% |
| 4 | Communication Services | 12.88% |
| 5 | Financials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
TSMC
TSM
$1.22T
| $545K | ﹤0.01% |
+26,275
| New | +$545K |
|
427
Vipshop
VIPS
$8.37B
| $537K | ﹤0.01% |
31,947
+18,035
| +130% | +$303K |
|
428
Vericel Corp
VCEL
$1.7B
| $531K | ﹤0.01% |
196,093
| – | – |
|
|
RDHL
429
Redhill Biopharma
RDHL
$2.82M
| $529K | ﹤0.01% |
41
+6
| +17% | +$77.4K |
|
430
Adverum Biotechnologies
ADVM
$66.5M
| $527K | ﹤0.01% |
6,395
+4,450
| +229% | +$367K |
|
431
Glaukos
GKOS
$5.17B
| $509K | ﹤0.01% |
21,050
-87,185
| -81% | -$2.11M |
|
432
Clean Harbors
CLH
$13.1B
| $508K | ﹤0.01% |
11,545
| – | – |
|
|
FWP
433
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $508K | ﹤0.01% |
+3,079
| New | +$508K |
|
|
MDCO
434
DELISTED
Medicines Co
MDCO
| $499K | ﹤0.01% |
+13,150
| New | +$499K |
|
|
ADAP
435
Adaptimmune Therapeutics
ADAP
$13.5M
| $497K | ﹤0.01% |
41,545
+13,100
| +46% | +$157K |
|
436
Ocular Therapeutix
OCUL
$2.21B
| $496K | ﹤0.01% |
35,307
| – | – |
|
437
Compañía de Cervecerías Unidas
CCU
$2.27B
| $487K | ﹤0.01% |
22,000
+7,000
| +47% | +$155K |
|
|
ARIA
438
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $483K | ﹤0.01% |
+82,650
| New | +$483K |
|
439
Itron
ITRI
$5.54B
| $480K | ﹤0.01% |
15,035
| – | – |
|
440
Aecom
ACM
$16.7B
| $479K | ﹤0.01% |
17,395
| – | – |
|
|
ONCE
441
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $453K | ﹤0.01% |
10,850
-2,000
| -16% | -$83.5K |
|
|
OTIC
442
DELISTED
Otonomy, Inc.
OTIC
| $420K | ﹤0.01% |
23,600
| – | – |
|
|
AMED
443
DELISTED
Amedisys
AMED
| $414K | ﹤0.01% |
+10,900
| New | +$414K |
|
444
Natera
NTRA
$22.9B
| $410K | ﹤0.01% |
+37,800
| New | +$410K |
|
|
EMC
445
DELISTED
EMC CORPORATION
EMC
| $409K | ﹤0.01% |
16,925
-98
| -0.6% | -$2.37K |
|
|
ZSPH
446
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $384K | ﹤0.01% |
+5,850
| New | +$384K |
|
447
Globant
GLOB
$2.75B
| $374K | ﹤0.01% |
+12,210
| New | +$374K |
|
448
Lindsay Corp
LNN
$1.5B
| $374K | ﹤0.01% |
5,510
| – | – |
|
449
NiSource
NI
$18.8B
| $371K | ﹤0.01% |
+20,000
| New | +$371K |
|
|
IMOS
450
ChipMOS TECHNOLOGIES
IMOS
$604M
| $362K | ﹤0.01% |
20,020
| – | – |
|